Step-wedge cluster-randomised community-based trials: An application to the study of the impact of community health insurance by De Allegri, Manuela et al.
BioMed  Central
Page 1 of 8
(page number not for citation purposes)
Health Research Policy and Systems
Open Access Research
Step-wedge cluster-randomised community-based trials: An 
application to the study of the impact of community health 
insurance
Manuela De Allegri*1, Subhash Pokhrel2, Heiko Becher1, Hengjin Dong1, 
Ulrich Mansmann3, Bocar Kouyaté4,6, Gisela Kynast-Wolf1, 
Adjima Gbangou5,6, Mamadou Sanon6, John Bridges7 and Rainer Sauerborn1
Address: 1Department of Tropical Hygiene and Public Health, University of Heidelberg, Germany, 2Health Economics Research Group (HERG), 
Brunel University, UK, 3Institute for Medical Informatics, Biometrics, and Epidemiology, University of Munich, Germany, 4Centre National de 
Recherche et de Formation sur le Paludisme, Ouagadougou, Burkina Faso, 5Direction des Etudes et de la Planification, Ministère de la Santé, 
Ouagadougou, Burkina Faso, 6Centre de Recherche en Santé de Nouna, Nouna, Burkina Faso and 7Bloomberg School of Public Health, Johns 
Hopkins University, USA
Email: Manuela De Allegri* - manuela.de.allegri@urz.uni-heidelberg.de; Subhash Pokhrel - Subhash.Pokhrel@brunel.ac.uk; 
Heiko Becher - heiko.becher@urz.uni-heidelberg.de; Hengjin Dong - dong@uni-heidelberg.de; Ulrich Mansmann - mansmann@ibe.med.uni-
muenchen.de; Bocar Kouyaté - bocar.crsn@fasonet.bf; Gisela Kynast-Wolf - Gisela.Kynast-Wolf@urz.uni-heidelberg.de; 
Adjima Gbangou - gbangou@pra.bf; Mamadou Sanon - sanon_mamadou@yahoo.fr; John Bridges - healtheconomics@hotmail.com; 
Rainer Sauerborn - rainer.sauerborn@urz.uni-heidelberg.de
* Corresponding author    
Abstract
Background: We describe a step-wedge cluster-randomised community-based trial which has
been conducted since 2003 to accompany the implementation of a community health insurance
(CHI) scheme in West Africa. The trial aims at overcoming the paucity of evidence-based
information on the impact of CHI. Impact is defined in terms of changes in health service utilisation
and household protection against the cost of illness. Our exclusive focus on the description and
discussion of the methods is justified by the fact that the study relies on a methodology previously
applied in the field of disease control, but never in the field of health financing.
Methods: First, we clarify how clusters were defined both in respect of statistical considerations
and of local geographical and socio-cultural concerns. Second, we illustrate how households within
clusters were sampled. Third, we expound the data collection process and the survey instruments.
Finally, we outline the statistical tools to be applied to estimate the impact of CHI.
Conclusion: We discuss all design choices both in relation to methodological considerations and
to specific ethical and organisational concerns faced in the field. On the basis of the appraisal of our
experience, we postulate that conducting relatively sophisticated trials (such as our step-wedge
cluster-randomised community-based trial) aimed at generating sound public health evidence, is
both feasible and valuable also in low income settings. Our work shows that if accurately designed
in conjunction with local health authorities, such trials have the potential to generate sound
scientific evidence and do not hinder, but at times even facilitate, the implementation of complex
health interventions such as CHI.
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Background
Community health insurance (CHI) has been identified
as a potentially valuable health financing alternative in
low and middle income countries since, through the pool-
ing of risks and resources, it promises to facilitate access to
health services and increase financial protection against
the cost of illness for vulnerable populations [1-5]. A
number of recent reviews, however, highlight how scanty
the evidence on the impact of CHI, defined in terms of its
effect on health service utilisation and protection against
the cost of illness, still is. They attribute this paucity
largely to weaknesses in the design of the studies, mostly
case studies and consultancy reports, which have so far
been conducted to evaluate the schemes [6-9]. Specifi-
cally, key difficulties in assessing the validity of the infor-
mation currently available on CHI are found to be related
to the absence of baseline data and control groups, diffi-
culties in sampling, the absence of control for confound-
ing variables, weak sources of data, and lack of clearly
defined outcome measures and indicators [6-9].
In this paper, we describe a step-wedge cluster-ran-
domised community-based trial which we have been con-
ducting since 2003 to accompany the implementation of
a CHI scheme in a rural region of West Africa. The study
aims to provide conclusive evidence on the impact of CHI
on health service utilisation and protection against the
cost of illness through the application of a trial design in
line with the standards set by the Cochrane Collaboration
through its Effective Practice and Organisation of Care
(EPOC) group [10,11]. Given our innovative approach to
evaluate the effects of a community-based intervention
(CHI), we describe the trial design and discuss it in rela-
tion both to methodological considerations and to spe-
cific ethical and organisational concerns faced in the field.
Our aim is to show that trials of this kind are feasible and
that they can effectively be pursued to assess the impact of
complex health policy interventions, such as health insur-
ance, and not only, as traditionally done, specific disease
control measures [12-14]. To our knowledge, only two
studies have previously attempted to use cluster randomi-
sation to evaluate the impact of health insurance pro-
grams in low income settings: one in India, described by
Ranson and colleagues [15-17], and one in Mexico,
described by King and colleagues [18]. Both studies, how-
ever, differ from the one described in this manuscript as
they adopted a different methodology, i.e. not a step-
wedge approach, and focused on assessing the impact of a
specific set of additional interventions nested within the
insurance program, rather than assessing the impact of the
insurance scheme per se.
Methods
Context
The trial described in this article has been conducted since
2003 in the Nouna Health District, a region located in
north-western Burkina Faso about 300 km from the capi-
tal Ouagadougou [19]. A demographic surveillance sys-
tem (DSS) is operative in a sub-portion of the health
district, covering a population of approximately 70,000
individuals who live in the catchment area of the Nouna
Hospital, located in the district capital, and of six first-line
health facilities located in the surrounding rural areas [20-
22]. Plans to initiate a CHI scheme in the district followed
the request of the Ministry of Health of Burkina Faso
[23,23] and were preceded by extensive research exploring
community perceptions of the quality of care, preferences
and willingness to pay (WTP) for a benefit package, cost
estimation analysis, risk perception and traditional net-
works of risk-sharing, health demand and health need
assessment [24-29].
Sample design
The area under demographic surveillance was subdivided
into 24 rural (villages) and 9 urban (town of Nouna) clus-
ters of approximately equal size. Clusters were purposely
not defined according to the catchment area of the exist-
ing first-line health facilities (Centre de Santé et Promo-
tion Social – CSPS) as their number changes
continuously, but continues to be too low to allow for
effective clustering. In 2003, the study area counted 4
CSPS; at the end of 2007, the number had increased to 7.
In order to smoothen variation across clusters, small
neighbouring villages were grouped to form one larger
cluster [13,14,30,31]. This was done in the respect of geo-
graphical proximity, in order to avoid potential conflicts
between neighbouring villages bound together by ethnic
and kin ties, in case they should be offered insurance at
different stages. The Burkinabè researchers assisted the
German statisticians in the selection of the clusters to bal-
ance the need to abide to the sample calculations with the
need to respect the local social context. This process was
facilitated by the wealth of information available on each
village thanks both to DSS data and to years of previous
anthropological research experience in the study area.
Given that clusters were purposely selected only within
the existing DSS area in the Nouna Health District, where
the CHI scheme was launched, the research team had no
ambition to claim that these clusters represented a ran-
dom sample from the population of all clusters nation-
wide.
The 33 clusters were then randomized to intervention and
control so that each year an additional 11 clusters were
offered the opportunity to join the CHI scheme. The inter-
vention was defined in terms of "offer to insure", given
that enrolment in CHI was and continues to be voluntary.Health Research Policy and Systems 2008, 6:10 http://www.health-policy-systems.com/content/6/1/10
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In 2004 (year 1), the first 11 clusters were offered insur-
ance. In 2005 (year 2), both the first 11 clusters and an
additional set of 11 clusters were offered insurance. In
2006 (year 3), the remaining 11 clusters were included in
the intervention so that all 33 clusters are currently offered
insurance (Figure 1). No further randomisation occurred
within clusters as all households residing in one cluster
were offered the possibility to join CHI at exactly the same
time [13].
The information needed to evaluate the impact of CHI is
collected through a household survey administered at
least once a year to a statistically representative sample of
all households residing in the DSS area. Given that the
CHI is set to accept exclusively the enrolment of entire
households, the sampling unit is the household, defined
as the basic socio-economic unit within which individuals
live together, share resources, and jointly satisfy their
needs under the authority of the household head [32].
The DSS provided the sampling frame for the household
survey. The sample size was estimated in advance to have
a 90% power of detecting an increase in health service uti-
lisation of one visit per year (Δ = 1) between insured and
non-insured households, assuming a 2-sided type I error
probability of 0.05 and, given the results of the prior WTP
study [28], an enrolment rate of at least 50%.
It was estimated that had the study relied on randomisa-
tion of individual households (i.e. offering the opportu-
nity to enrol to selected single households in the study
area), a sample of 378 households would have been suffi-
cient (189 per intervention arm) to detect a difference of
one (Δ = 1) between insured and non-insured assuming a
standard deviation of σ = 3 which appears a realistic value
given a priori information. These calculations were based
on the equation:
where uα/2 and uβ are the quantiles of the normal distribu-
tion and σ is the standard deviation of the number of vis-
its per year.
Given cluster randomisation however, a design factor of
2.16 was applied to adjust for intra-cluster correlation
coefficient (ρ) [14,31,33]. Using standard ANOVA calcu-
lations in fact [31], the analysis of a prior household sur-
vey conducted in the area in 2002 revealed that the intra-
cluster correlation coefficient (ρ) for relevant variables
(household socioeconomic status, proportion of house-
hold members reporting at least fair health, household
spending on medical care) had a median of 0.04 (see
Additional File 1). The number of households per cluster
was set at m = 30. Thus, the basic sample size equation
was modified as following:
to estimate that the minimum required sample should
include 816 households distributed across 27 clusters.
The minimum sample size was then increased to 990
households distributed across 33 clusters both to simplify
the intervention by creating clusters in the respect of geo-
graphical proximity and feasibility, as explained in detail
earlier, and to allow for a potential loss to follow up of
15%.
Data collection and survey instruments
The survey collects information separately for each mem-
ber of the households in the sample and covers all of the
following areas: socio-demographic characteristics,
income, expenditure, assets, illness reporting, and health
care seeking behaviour, including health expenditure
[32]. Two ad hoc modules, relevant to the evaluation of
CHI, are administered to all people aged 15 and above.
One, administered already at baseline in 2003 (year 0),
assesses participation in traditional risk-sharing arrange-
ments; and one, administered for the first time only at the
end of the first enrolment campaign in 2004 (year 1),
explores reasons motivating the decision to join or not to
join the scheme. Household survey data are comple-
mented with DSS data, providing information on village
characteristics (e.g. village size, presence of a school, pres-
ence of a health facility), and with insurance data, provid-
ing information on the CHI campaign and overall village
enrolment behaviour (e.g. number of sensitisation visits,
sensitisation tools applied, enrolment status of village
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leaders). The quality of the data source is secured by a
comprehensive control process, starting with the training
and the direct supervision of field interviewers and ending
with the verification of each questionnaire entered in the
database [32].
Data analysis
Given the study design, the impact of CHI is being
assessed by comparing health service utilisation and pro-
tection against the cost of illness between insured and
non-insured households, both within and across clusters.
The impact of CHI on health service utilisation is being
assessed by measuring differences in the number of cura-
tive visits to a health facility and delay to treatment given
illness. In the short term, the impact of CHI on protection
against the cost of illness is being assessed by measuring
differences in catastrophic health spending. In the
medium and long term, the impact of CHI on protection
against the cost of illness can also be assessed by measur-
ing differences in socio-economic status. Given that the
intervention will stretch over a period of several years, the
analysis needs to be adjusted for the time of the study
allowing a better understanding of possible sources of
bias.
Two important design issues need to be addressed in the
analysis. First, statistical analysis ought to take into
account that while the intervention is targeted at the clus-
ter level, outcomes can only be assessed at the level of the
household, thus requiring the application of hierarchical
modelling techniques addressing the issue of intra-cluster
correlation [14,31,34-37]. Preliminary analysis of the sur-
vey data has so far confirmed that the intra-cluster corre-
lation coefficient (ρ) estimated to derive an adequate
sample size calculations does in fact reflect the reality of
the field trial [38]. Second, analysis ought to be corrected
for the bias which arises from self-selection into the insur-
ance scheme. Households with specific characteristics
may in fact be more likely to purchase insurance than oth-
ers [39], thus a direct comparison between insured and
non-insured households would be likely to produce
biased conclusions that may merely reflect the lack of ini-
tial comparability [40,41].
A number of methods have been developed to address
selection bias in such an analysis [42-50]. Up to the third
round of enrolment, propensity score techniques can be
used to adjust for differences between insured and non-
insured groups in a non-biased way by matching the self-
selected treatment group, i.e. those having joined CHI,
with an appropriate control group of people not having
been offered CHI [40,41,51,52].
The information which has emerged from the analysis of
enrolment behaviour following the end of the first round
of enrolment has been used to inform the construction of
propensity scores [39]. A first round of analysis on the
effect of insurance status in improving access to care sug-
gested a 40% increase in the number of outpatient visits
and a 2% increase in the number of inpatient visits among
insured people when compared to the uninsured people
[53]. This analysis, which applied propensity score match-
ing to account for potential selection bias into the scheme,
used the Kernel matching method to estimate the average
treatment effect on treated, i.e. the effect of insurance on
access to care [53]. A limitation of such an analysis, how-
ever, is due to its ability to correct bias only on the basis
of observable characteristics which determine self-selec-
tion. Thus, such an analysis is able to correct bias only par-
tially.
After the third round of enrolment, once all households in
all clusters have been offered the opportunity to join CHI,
another set of techniques, primarily used in the analysis of
observational data, ought to be applied to the trial data to
assess the impact of CHI once the control group ceases to
exist [54]. These techniques include behavioural models
such as that of sample selection [42,44,45,47,48,50] and
treatment effects and multivariate probit [43,55]. Analys-
ing the impact of CHI from different techniques will pro-
vide robustness of the evidence imparted by the field trial.
Discussion
EPOC guidelines value randomised controlled trials
(RCTs) as the "gold standard" of study design. They recog-
nise, however, that individual randomisation may not
always be feasible and that, alternative study designs, such
as cluster-randomised trials, may be better suited to pro-
vide adequate evidence on the impact of complex health
interventions, including health system interventions
[10,36,56]. In recent years, a number of researchers have
been working on developing adequate methodologies to
conduct cluster-randomised trials, reinforcing trust in
how such trials can produce reliable evidence in situations
when group randomization is to be preferred to individ-
ual one [14,30,31,33,34,37,57]. With the exclusion of the
trial conducted by Ranson and colleagues in rural India
[15-17] and of the trial conducted by King and colleagues
in Mexico [18], however, research concerned with evaluat-
ing the impact of health financing interventions, includ-
ing CHI, has mostly forgone the opportunity to take
advantage of such methodological developments, thus
failing to establish the evidence-base needed for health
policy [6-9].
Our approach to the evaluation of CHI is therefore inno-
vative and has the potential to produce sound evidence on
the impact of such financing arrangement on health serv-
ice utilisation and protection against the cost of illness.
Furthermore, our research design and testimony of its fea-Health Research Policy and Systems 2008, 6:10 http://www.health-policy-systems.com/content/6/1/10
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sibility under field conditions confirms the political
acceptability of such trials already amply discussed by
King and colleagues (2007)[18] and may serve as an
example for the evaluation of other complex health sys-
tem interventions, including other systems of health
financing, adding to the very limited number of studies
which have so far adopted comparably sound study
designs [54,58-60].
In the specific case described in this article, a cluster-ran-
domised community-based trial was preferred to a "sim-
ple" RCT since the latter would have posed both
operational and ethical problems as single households
within the same community would have had to be
selected to receive the intervention, i.e. the offer to insure
[14,31,36]. Contrary to the RAND experiment, which
starting in the early 1970s randomised single American
families to receive differential insurance coverage [54],
communities in the study area would have objected indi-
vidual randomisation, not only refusing to participate in
the initiative, but potentially also withdrawing their trust
from other activities managed by the health district and by
the CRSN. This is most often likely to be the case faced by
researchers working in societies with a collective orienta-
tion, whether in sub-Saharan Africa, Asia, or South Amer-
ica. In addition to limiting conflict both within and across
communities, the adoption of cluster randomisation has
minimised the researchers' interference with the work of
the CHI management team, which has been able to man-
age the intervention (i.e. the implementation of the CHI
scheme) directly. The research team has followed the
work of the CHI management unit only from a distance,
allowing for the initiative to be "owned" by the commu-
nity. Qualitative research conducted in the area following
the end of the first enrolment campaign showed that such
an approach has substantially increased the acceptability
of the CHI scheme as well as that of the accompanying
study [61].
In addition, the step-wedge nature of the study has
ensured that all communities would progressively be
included the intervention. This represents a clear depar-
ture from previous studies, including the recent trial by
Ranson and colleagues [15-17] and the one by King and
colleagues [18], which also applied randomisation to
understand the impact of health financing interventions.
These studies in fact, entailed no possibility for the indi-
viduals or communities in the control areas to benefit
from the intervention at a later stage [54,58-60]. What
concerns were initially raised against the fact clustering
entailed that some communities enjoyed the right to join
the scheme earlier than others, were resolved through
open discussion with the community in the light of the
fact that, given the limited resources available, the CHI
management team and the health district would inevita-
bly have to carry out the intervention in a progressive
manner regardless of the research. Thus, the application of
a cluster-randomised community-based trial rather
favoured the project implementation as it allowed ran-
dom allocation of the intervention across communities,
minimising possible grievances and complaints.
The step-wedge nature of the trial also allowed to mini-
mise the spill over effect, as the incentive to migrate to a
different area just to benefit from the intervention was
counterbalanced by the fact that this very same interven-
tion was going to reach the entire study area within a
period of three years. The spill over effect was and contin-
ues to be further contained by the strict control on enrol-
ment procedure which can be secured thanks to the
availability of DSS data. During each enrolment campaign
in fact, the CHI management unit checks on the DSS
records that the people joining the scheme are actual resi-
dents of a given village. The DSS records as residents only
those people who have resided for at least six months in a
given village. Therefore, the CHI scheme runs no risk of
enrolling people who have migrated temporarily with the
only objective of joining the scheme.
The use of a cluster-randomised trial is often justified in
terms of its ability to capture the overall effect of an inter-
vention more adequately than a RCT [14,30,31]. Contam-
ination across individuals is usually discussed in terms of
infectiousness and susceptibility, often justifying the adop-
tion of cluster-randomised trials for the evaluation of
interventions targeting infectious diseases [14]. Although
in the case of CHI, concepts of infectiousness and suscepti-
bility do not apply as such, one needs to acknowledge the
specific dynamic nature of the intervention. CHI in fact, is
inscribed within the local social setting, with promotion
campaigns delivering health messages to the entire popu-
lation and with insured and non-insured households
across clusters being bound together by ethnic and kin
ties. Information is therefore inevitably shared both
across insured and non-insured households and across
clusters, possibly inducing some changes in the outcome
variables regardless of insurance status. Unlike a RCT, a
cluster-randomised trial allows for such mass effects to be
captured [14,30,31], providing a more realistic estimation
of the overall impact of the intervention on the commu-
nity. Still, in order to limit the potential effect of cross-
contamination across households and clusters on under-
estimating the impact of the intervention, we grouped
together several neighbouring villages to form a cluster,
although we had no other means of specifically control-
ling for the proximity of control and treatment clusters.
This has served the purpose of smoothing variation
between clusters, thus increasing statistical efficiency in
the analysis [14,30,31], while also facilitating the imple-
mentation of the intervention.Health Research Policy and Systems 2008, 6:10 http://www.health-policy-systems.com/content/6/1/10
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The study design described in this article allows to offset
the limitations to the evaluation of CHI which have
emerged in the literature [6-9]. The adoption of a cluster-
randomised trial secures the recruitment of both cases, i.e.
people who join CHI, and controls, i.e. people who do
not join CHI, while analytical tools based on hierarchical
modelling and propensity score techniques allow to min-
imise possible bias due to intra-cluster correlation and to
the bias which arises from self-selection into the insurance
scheme [13,14,34,40,41]. Furthermore, the field trial data
will also allow other modelling techniques to be as appli-
cable, thus offering a unique opportunity to compare
results and validate evidence emerging from alternative
analytical constructs. The adequacy of sampling was
ensured by the fact that the sample selected for inclusion
in the household survey took into account a design factor
of 2.16 to compensate for cluster randomisation
[14,30,31,33] and that preliminary analysis following the
trial implementation confirmed that such design factor
was suitable given the intra-cluster correlation coefficient
detected on the field [38].
The wealth of information gathered through means of the
household survey, the DSS, and the insurance records
allows the statistical analysis to account for possible con-
founding factors both at the household and at the com-
munity level [13,36]. Having conducted a round of the
household survey just before the launching of the insur-
ance scheme ensures the availability of baseline data to be
included in the statistical analysis.
It needs to be noted, however, that as the trial proceeds,
the evaluation of the intervention is challenged by an
enrolment rate which has been steadily increasing since
the launch of the scheme (from 4.8% in 2004 to 8% in
2007), but which remains well below the expectations of
the scheme initiators, although perfectly in line with most
other experiences described in the literature [62]. The low
enrolment rate has forced the research team to adapt the
methodology originally envisioned in itinere, adopting
methodological strategies which have proved to be more
complex than what originally expected [53].
Conclusion
Our experience conducting a step-wedge cluster-ran-
domised community-based trial shows that the applica-
tion of such studies is feasible to evaluate complex health
interventions, even when working in resource-limited set-
tings, and provides a unique opportunity to produce
sound evidence for decision-making in health policy. In
line with what reported by King and colleagues
(2007)[18], our experience further shows that if accu-
rately designed in conjunction with local health authori-
ties, such trials do not to hinder the implementation of
the intervention, but rather facilitate it with regard to
some specific aspects. Given the scanty evidence currently
available to adequately assess the impact of different
health financing interventions, especially CHI [6-9], the
research approach adopted by our team may be replicated
in other settings as a means of contributing to evidence-
based decision-making in health care. Similarly, our expe-
rience suggests that given their feasibility and their valua-
ble potential to inform decision-making, researchers are
therefore encouraged to use such trial designs and apply
them to the study of other complex health policy interven-
tions.
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